In a dedicated food-effect study published in Clinical Pharmacology and Therapeutics in 2024, orforglipron absorption was evaluated under fasting conditions and following a high-fat, high-calorie meal (the standard FDA food-effect test meal containing approximately 50% of calories from fat and 800-1000 total calories)
Off-label means the drug is being prescribed for a condition that it was not originally designed for
While there are no approved indications for using GLP-1 agonists specifically for the treatment of lipedema, these medications have shown numerous health benefits for women with dozens of medical conditions, such as Diabetes, Heart Disease, Kidney Disease, Parkinsons Disease, and Obesity, as well as for women without any existing medical problems
Or you can send us an appointment request with a few suggested dates and times and we'll contact you with some options.
For Media Inquiries and AHA Expert Perspective: AHA Communications & Media Relations in Dallas: 214-706-1173